Results 111 to 120 of about 859,888 (229)
Residual and recurrent tricuspid regurgitation may occur frequently after surgical tricuspid valve repair. However, reoperation for tricuspid regurgitation is rare, although many patients are again highly symptomatic. Tricuspid transcatheter edge-to-edge
Jafer Haschemi (14023287) +4 more
core +1 more source
ABSTRACT Pulmonary hypertension (PH) is common in patients undergoing transcatheter mitral edge‐to‐edge repair (M‐TEER) and is an established determinant of adverse outcomes after intervention. Importantly, persistent PH after technically successful M‐TEER remains associated with ongoing symptoms, right ventricular dysfunction and poor prognosis, yet ...
Xiang Chen +7 more
wiley +1 more source
Residual and recurrent tricuspid regurgitation may occur frequently after surgical tricuspid valve repair. However, reoperation for tricuspid regurgitation is rare, although many patients are again highly symptomatic. Tricuspid transcatheter edge-to-edge
Jafer Haschemi (14023287) +4 more
core +1 more source
Choosing Between Tricuspid Repair or Replacement: Decision Algorithms
Transcatheter tricuspid valve (TV) interventions have transformed the treatment of TV disease. Among available therapies, transcatheter tricuspid edge-to-edge repair has shown favorable safety, symptom relief, quality-of-life improvement, and reduction ...
Hannah Kempton, MD +8 more
doaj +1 more source
ABSTRACT Introduction Patients with repaired tetralogy of Fallot (rTOF) remain at risk of ventricular tachycardia (VT). This risk is most commonly related to slow conduction within the septal isthmus, which is defined as the region between the ventricular septal defect (VSD) patch and adjacent valvular annuli.
Yuki Matsuoka +8 more
wiley +1 more source
Transcatheter tricuspid valve replacement
Despite the explosion in the field of transcatheter aortic valve implantations over the last 10 years, only a handful of transcatheter tricuspid valve-in-valve implants have been described to date. This review describes the basic anatomy and pathology of
Weich H.
core
ANTecedent Annular Reduction to Facilitate TransCatheter TrICuspid Valve Replacement (ANTARCTIC).
BACKGROUND: Transcatheter tricuspid valve implantation may not be possible when annular size is very large. CASE SUMMARY: We present an 85-year-old man who developed NYHA functional class III symptoms and recurrent heart failure hospitalizations due to ...
Bloomingdale, Richard +7 more
core +1 more source
Transcatheter aortic and pulmonary valves have been used to treat stenosis or regurgitation after prior surgical tricuspid valve (TV) replacement or repair.
Kreutzer, Jacqueline N. +30 more
core +1 more source
Transcatheter aortic-valve replacement for inoperable severe aortic stenosis. [PDF]
BACKGROUND: Transcatheter aortic-valve replacement (TAVR) is the recommended therapy for patients with severe aortic stenosis who are not suitable candidates for surgery. The outcomes beyond 1 year in such patients are not known.
Makkar, Raj R +26 more
core +1 more source
Residual and recurrent tricuspid regurgitation may occur frequently after surgical tricuspid valve repair. However, reoperation for tricuspid regurgitation is rare, although many patients are again highly symptomatic. Tricuspid transcatheter edge-to-edge
Jafer Haschemi (14023287) +4 more
core +1 more source

